Pharmaxis Ltd. PXSLY Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Pharmaxis Ltd. PXSLY Company Overview 

Stock Message Board http://investorshangout.com/search?q=PXSLY&am...mp;yt1=Go!

Pharmaxis Ltd. PXSLY Current Price and Quotes
1.92
Previous Close
1.92
Open
N/A

Daily Range
N/A - N/A
52wk Range
20.38 - 1.92

Volume
0
Dividend
N/A

Average Vol (3m)
691
Yield
N/A

Pharmaxis Ltd. PXSLY
Company Information
Unit 2
10 Rodborough Road
Frenchs Forest NSW 2086
Australia

Website: http://www.pharmaxis.com.au
Phone: 011-61-2-9454-7200

Pharmaxis Ltd. PXSLY
Pharmaxis Ltd. PXSLY
Financial Reportings and Disclosures
Reporting Status International Reporting: ASX - Australian Securities Exchange
Deregistered a/o Aug 03, 2009
Latest Report Jun 30, 2008 20-F
CIK 0001301357
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Australia
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Alan Robertson CEO
David McGarvey CFO
Company Directors
Denis Michael Hanley Chairman
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pharmaxis Ltd. PXSLY
PXSLY Security Details Other Company Securities
Share Structure
Market Value1 $29,221,158 a/o Aug 30, 2013
Shares Outstanding 228,290,300 a/o Jul 21, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend () *  Jun 01, 2007
Dividend (0.00) *  Jun 01, 2007
Dividend (0.00) Jun 06, 2007 Jun 01, 2007 Jun 05, 2007
Non US Stock Exchange Listing
PXS - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 355 (0%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
BNY Mellon

Pharmaxis Ltd. PXSLY Recent News

Pharmaxis Ltd. PXSLY Financials
PXSLY

PXSLY Pharmaxis Ltd. Research DD Guide

PXSLY Pharmaxis Ltd. Stock Message Board http://investorshangout.com/search?q=PXSLY&am...mp;yt0=Go!
PXSLY Pharmaxis Ltd. Stock Quote http://www.otcmarkets.com/stock/PXSLY/quote
PXSLY Pharmaxis Ltd. Stock Chart http://www.otcmarkets.com/stock/PXSLY/chart
PXSLY Pharmaxis Ltd. Company Info http://www.otcmarkets.com/stock/PXSLY/company-info
PXSLY Pharmaxis Ltd. Recent News http://www.otcmarkets.com/stock/PXSLY/news
PXSLY Pharmaxis Ltd. Financials http://www.otcmarkets.com/stock/PXSLY/financials
PXSLY Pharmaxis Ltd. Filings and Disclosure http://www.otcmarkets.com/stock/PXSLY/filings
PXSLY Pharmaxis Ltd. Short Sales http://www.otcmarkets.com/stock/PXSLY/short-sales
PXSLY Pharmaxis Ltd. Insider Disclosure http://www.otcmarkets.com/stock/PXSLY/insider-transactions
PXSLY Pharmaxis Ltd. Research Reports http://www.otcmarkets.com/stock/PXSLY/research
PXSLY Pharmaxis Ltd. Summary http://finance.yahoo.com/q?s=PXSLY
PXSLY Pharmaxis Ltd. Historical Prices http://finance.yahoo.com/q/hp?s=PXSLY+Historical+Prices
PXSLY Pharmaxis Ltd. Interactive Chart http://finance.yahoo.com/echarts?s=PXSLY
PXSLY Pharmaxis Ltd. Basic Chart http://finance.yahoo.com/q/bc?s=PXSLY+Basic+Chart
PXSLY Pharmaxis Ltd. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PXSLY+Basic+Tech.+Analysis
PXSLY Pharmaxis Ltd. Headlines http://finance.yahoo.com/q/h?s=PXSLY+Headlines
PXSLY Pharmaxis Ltd. Press Releases http://finance.yahoo.com/q/p?s=PXSLY+Press+Releases
PXSLY Pharmaxis Ltd. Company Profile http://finance.yahoo.com/q/pr?s=PXSLY+Profile
PXSLY Pharmaxis Ltd. Key Statistics http://finance.yahoo.com/q/ks?s=PXSLY+Key+Statistics
PXSLY Pharmaxis Ltd. Industry http://finance.yahoo.com/q/in?s=PXSLY+Industry
PXSLY Pharmaxis Ltd. Major Holders http://finance.yahoo.com/q/mh?s=PXSLY+Major+Holders
PXSLY Pharmaxis Ltd. Insider Transactions http://finance.yahoo.com/q/it?s=PXSLY+Insider+Transactions
PXSLY Pharmaxis Ltd. Insider Roster http://finance.yahoo.com/q/ir?s=PXSLY+Insider+Roster
PXSLY Pharmaxis Ltd. Income Statement http://finance.yahoo.com/q/is?s=PXSLY
PXSLY Pharmaxis Ltd. Balance Sheet http://finance.yahoo.com/q/bs?s=PXSLY
PXSLY Pharmaxis Ltd. Cash Flow http://finance.yahoo.com/q/cf?s=PXSLY+Cash+Flow&annual
PXSLY Pharmaxis Ltd. Nasdaq http://www.nasdaq.com/symbol/PXSLY
PXSLY Pharmaxis Ltd. Market Watch http://www.marketwatch.com/investing/stock/PXSLY
PXSLY Pharmaxis Ltd. Bloomberg http://www.bloomberg.com/quote/PXSLY:US
PXSLY Pharmaxis Ltd. Morningstar http://quotes.morningstar.com/stock/s?t=PXSLY
PXSLY Pharmaxis Ltd. Bussinessweek http://investing.businessweek.com/research/st...cker=PXSLY
PXSLY Pharmaxis Ltd. Barchart http://www.barchart.com/quotes/stocks/PXSLY
PXSLY Pharmaxis Ltd. OTC Short Report http://otcshortreport.com/index.php?index=PXSLY
PXSLY Pharmaxis Ltd. Investopedia http://www.investopedia.com/markets/stocks/PXSLY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading